The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy
AbstractGhrelin, discovered in 1999, is a 28-amino-acid hormone, best recognized as a stimulator of growth hormone secretion, but with pleiotropic functions in the area of energy homeostasis, such as appetite stimulation and energy expenditure regulation. As the intrinsic ligand of the growth hormone secretagogue receptor (GHS-R), ghrelin appears to have a broad array of effects, but its primary role is still an area of debate. Produced mainly from oxyntic glands in the stomach, but with a multitude of extra-metabolic roles, ghrelin is implicated in complex neurobiological processes. Comprehensive studies within the areas of obesity and metabolic surgery have clarified the mechanism of these operations. As a stimulator of growth hormone (GH), and an apparent inducer of positive energy balance, other areas of interest include its impact on carcinogenesis and tumour proliferation and its role in the cancer cachexia syndrome. This has led several authors to study the hormone in the cancer setting. Ghrelin levels are acutely reduced following an oesophagectomy, a primary treatment modality for oesophageal cancer. We sought to investigate the nature of this postoperative ghrelin suppression, and its neurobiological implications. View Full-Text
Share & Cite This Article
Murphy, C.F.; le Roux, C.W. The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy. Int. J. Mol. Sci. 2017, 18, 35.
Murphy CF, le Roux CW. The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy. International Journal of Molecular Sciences. 2017; 18(1):35.Chicago/Turabian Style
Murphy, Conor F.; le Roux, Carel W. 2017. "The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy." Int. J. Mol. Sci. 18, no. 1: 35.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.